FDAnews Drug Daily Bulletin

First Trial of Vaccine to Treat Parkinson’s Disease Begins

June 11, 2012
The Austrian company AFFiRiS A.G. of Vienna said this week it has begun the first-ever clinical trials of a vaccine to treat Parkinson’s disease. The study of as many as 32 patients is designed to test the safety and tolerability of the vaccine, called PD01A.
Los Angeles Times